AbbVie (ABBV) Set to Report Q3 Results: Can Things Turnaround?

AbbVie (ABBV) is set to report its third quarter results before the opening bell on Friday, November 1. The large cap pharmaceutical company has seen its shares decline over 15% in 2019 thus far, lagging behind the broader pharma market’s gain.